🎁 Black Friday: up to 50% off of annual plans
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
121.40
-2.62 (-2.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Protagonist Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
342.26-130.15275.19-78.96-127.39-125.55
Depreciation & Amortization
1.591.282.93.313.372.78
Loss (Gain) From Sale of Investments
-4.5-7.22-8.88-4.57-0.551.83
Stock-Based Compensation
53.6245.9737.5529.2924.216.4
Other Operating Activities
1.661.58-0.19--
Change in Accounts Receivable
-287.21164.88-155-9.991.560.86
Change in Accounts Payable
0.263.720.84-2.872.05-1.39
Change in Unearned Revenue
-0.68-21.0230.57--1.6-12.88
Change in Income Taxes
4.22-2.692.69---
Change in Other Net Operating Assets
-1.311.31-1.71-6.65-9.7710.09
Operating Cash Flow
109.9157.67184.15-70.24-108.14-107.87
Operating Cash Flow Growth
67.89%-68.68%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.76-1.59-1.36-0.61-0.8-1.1
Investment in Securities
231.48-47.74-298.13-38.6592.26-14.76
Investing Cash Flow
230.71-49.33-299.48-39.2691.47-15.86

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
49.7523.3426.45171.2519130.11
Repurchase of Common Stock
-5.79-0.48-0.6-0.77-0.19-0.19
Other Financing Activities
----0.03-
Financing Cash Flow
43.9622.8625.85170.4818.84129.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-----0.09-0.13
Net Cash Flow
384.5931.2-89.4860.982.086.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
109.1556.08182.8-70.85-108.93-108.97
Free Cash Flow Growth
71.32%-69.32%----
Free Cash Flow Margin
19.78%121.87%42.08%-118.08%-409.81%-398.31%
Free Cash Flow Per Share
1.570.882.81-1.25-2.22-2.35
Levered Free Cash Flow
-24.01105.6265.11-43.31-60.37-61.59
Unlevered Free Cash Flow
-24.01105.6265.11-43.31-60.37-61.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
3.693.691.53---
Change in Working Capital
-284.73146.21-122.61-19.51-7.77-3.31
SEC Filings: 10-K · 10-Q